Allakos Inc. (ALLK)
Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.
Address
825 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
Founded
2012
Number of Employees
131
Website
http://www.allakos.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)